Caicun Zhou

Shanghai Pulmonary Hospital ORCID: 0000-0002-1072-9941

1

h-index

1

Publications

1,356

Citations

Publications

1 shown

Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial

Enriqueta Felip , Nasser K. Altorki , Caicun Zhou +18 more

2021 The Lancet 1356 citations

Frequent Co-Authors

Enriqueta Felip

Vall d'Hebron Institute of Oncology

Nasser K. Altorki

Cornell University

Tibor Csőszi

Université Toulouse III - Paul Sabatier

Ihor Vynnychenko

Sumy State University

Oleksandr Goloborodko

National University Zaporizhzhia Polytechnic

Alexander Luft

Leningrad Regional Cancer Center

Researcher Info

h-index: 1
Publications: 1
Citations: 1,356
Institution: Shanghai Pulmonary Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1072-9941

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.

Academic Output Over Time